24,200 Shares in HealthEquity, Inc. $HQY Acquired by Expect Equity LLC

Expect Equity LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 24,200 shares of the company’s stock, valued at approximately $2,186,000.

Several other large investors have also recently bought and sold shares of HQY. Fifth Third Wealth Advisors LLC grew its position in shares of HealthEquity by 4.2% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after purchasing an additional 116 shares in the last quarter. Truist Financial Corp raised its position in shares of HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after buying an additional 119 shares in the last quarter. Fiduciary Trust Co boosted its stake in HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after buying an additional 120 shares during the period. Larson Financial Group LLC boosted its stake in HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after buying an additional 123 shares during the period. Finally, Merit Financial Group LLC grew its position in HealthEquity by 8.9% during the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after buying an additional 172 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on HQY shares. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Barrington Research reiterated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research report on Monday, June 1st. Finally, Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday. Eleven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Stock Down 0.0%

Shares of NASDAQ:HQY opened at $105.39 on Wednesday. The firm has a market capitalization of $8.81 billion, a PE ratio of 39.47, a price-to-earnings-growth ratio of 1.77 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The firm has a fifty day moving average of $97.41 and a 200 day moving average of $87.53.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The business’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, research analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insider Activity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the sale, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. The trade was a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.